Amendments underway to the Drugs Rules; proposes parallel submission of applications for grant of renewal of manufacturing and sales license for large volume parenterals, vaccines and (r-DNA) derived drugs etc. comments invited till 22.06.202
Amendments underway to the Drugs Rules; proposes parallel submission of applications for grant of renewal of manufacturing and sales license for large volume parenterals, vaccines and (r-DNA) derived drugs etc. comments invited till 22.06.202
You need to be logged in to view this content. Please Log In. Not a Member? Join Us